Bronchiectasis is a syndrome characterized by endobronchial suppuration, inflammation, and impaired mucus clearance with the end result of chronic microbial infection and progressive decline in lung function [ 1 ]. Clinically, it is defined by …

In 2022, the global mortality rate of lung cancer still ranks first among the top 10 tumors [ 1 ]. Non-small cell lung cancer (NSCLC) accounts for about 80-85% of lung cancer, has higher heterogeneity and invasiveness [ 2 ]. The next-generation …

In recent years, clinicians, health service providers, researchers, the pharmaceutical industry, reimbursement agencies and health policymakers have been increasingly recognizing the importance of measuring health-related-quality of life (HRQoL) [ …

Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome characterized by the development of hundreds to thousands of colorectal adenomatous polyps, resulting in colorectal cancer (CRC) in the majority of patients by the age of 40–50 …

Levothyroxine (L-T4) - being the mainstay treatment for hypothyroidism - has been one of the top ten prescribed medications in the past decade [ 1 ]. However, 11% to 42% of hypothyroid patients on L-T4 are under-replaced [ 2 ]. Low or non-adherence …

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder initiated by dysregulation of T and B lymphocytes. Its pathology includes expansion of B cells, which leads to formation of autoantibodies [ 1 ]. Bruton’s tyrosine kinase (BTK) is …

Lung cancer is the most common cancer worldwide and has the highest mortality rate [ 1 ]. Non-small cell lung cancer (NSCLC) accounts for 85% of all cases of lung cancer, with a 5-year survival rate of only 21% [ 2 ]. Currently, surgery …

Die vorliegende Studie prüft auf der Basis der Daten der deutschen Teilstichprobe der europäischen Unternehmenserhebung über neue und aufkommende Risiken (ESENER) aus den Jahren 2014 und 2019 den Zusammenhang zwischen der Güte der betrieblichen …

Eine 63-jährige Frau mit Lungenkarzinom stellt sich mit plötzlicher Reduktion des Allgemeinzustands, Erbrechen und ausgeprägter Schwäche vor. Sie berichtet aktuell eine Chemotherapie zu erhalten, daher werden die Symptome als Nebenwirkung der Zytostatika interpretiert. In der weiteren Diagnostik zeigt sich dann eine Ketoazidose, die sich durch die verzögert beschafften Vorbefunde erklären lässt.